KEGG   DISEASE: ミオクロニー脱力発作を伴うてんかん
エントリ  
H01823                                                             
名称    
ミオクロニー脱力発作を伴うてんかん;
ドーゼ症候群
  下位グループ
ミオクローヌス-脱力発作てんかん [DS:H02361]
  上位グループ
症候性全般てんかん [DS:H00577]
概要    
Myoclonic astatic epilepsy (MAE), also known as Doose syndrome, is a generalized epilepsy syndrome of young children that includes multiple different seizure types, of which myoclonic and astatic seizures were the most prominent. The electro- encephalogram (EEG) tracings may be normal initially, but later develop a characteristic biparietal theta background rhythm, and irregularly generalized spike wave, and polyspike wave discharges. In general, children are developmentally normal before the onset of epilepsy and organic brain abnormalities are absent. Long-term prognosis varies from cessation of seizures with normal developmental outcome to intractable epilepsy with mental retardation. Favorable outcomes were reported in half to two-thirds of cases. Treatment strategies such as corticosteroids, ethosuximide, and valproate have been described as only partially effective, but newer anticonvulsants, such as levetiracetam and zonisamide, may provide additional seizure control. The most effective treatment reported to date appears to be the ketogenic diet.
カテゴリ  
神経系疾患
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 08 神経系の疾患
  てんかんまたは発作
   8A61  主にてんかんとして発現する遺伝的または推定される遺伝的症候群
    H01823  ミオクロニー脱力発作を伴うてんかん
指定難病 [jp08407.html]
 H01823
リンク   
ICD-11: 8A61.22
ICD-10: G40.4
MeSH: D004831
文献    
  著者
Kelley SA, Kossoff EH
  タイトル
Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress.
  雑誌
Dev Med Child Neurol 52:988-93 (2010)
DOI:10.1111/j.1469-8749.2010.03744.x
文献    
  著者
Kilaru S, Bergqvist AG
  タイトル
Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia.
  雑誌
Epilepsia 48:1703-7 (2007)
DOI:10.1111/j.1528-1167.2007.01186.x
LinkDB    

» English version

DBGET integrated database retrieval system